nitrendipine has been researched along with Eaton-Lambert Myasthenic Syndrome in 2 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meriney, SD | 1 |
Hulsizer, SC | 1 |
Lennon, VA | 1 |
Grinnell, AD | 1 |
Peers, C | 1 |
Lang, B | 1 |
Newsom-Davis, J | 1 |
Wray, DW | 1 |
2 other studies available for nitrendipine and Eaton-Lambert Myasthenic Syndrome
Article | Year |
---|---|
Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Topics: Autoantibodies; Barium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Small Cell; Cell Cycl | 1996 |
Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
Topics: Action Potentials; Animals; Antibodies, Neoplasm; Calcium Channels; Cell Line; Glioma; Humans; Immun | 1990 |